CT Financial Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

CT Financial Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$47.2K	Hold	1,175	–	–	0.03%	279
2016 Q4	$56.2K	Hold	1,175	–	–	0.04%	255
2016 Q3	$43.1K	Sell	1,175 -550	-32%	-$17.2K	0.03%	284
2016 Q2	$40.2K	Sell	1,725 -1,000	-37%	-$32.3K	0.02%	292
2016 Q1	$110K	Sell	2,725 -1,535	-36%	-$62.3K	0.06%	202
2015 Q4	$264K	Sell	4,260 -1,840	-30%	-$99.3K	0.15%	118
2015 Q3	$247K	Sell	6,100 -1,100	-15%	-$56.9K	0.15%	118
2015 Q2	$414K	Hold	7,200	–	–	0.24%	100
2015 Q1	$458K	Buy	7,200 +4,875	+210%	+$331K	0.25%	96
2014 Q4	$144K	Buy	+2,325	New	+$115K	0.11%	140
2014 Q1	$458K	Buy	+7,200	New	+$349K	0.25%	96

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

CT Financial Advisors's IONS Position: Q1 2017 in Review

CT Financial Advisors held its Ionis Pharmaceuticals (IONS) position steady in Q1 2017 at 1,175 shares worth $47.2K. The position accounts for 0.03% of the portfolio, ranked #279.

CT Financial Advisors first reported a position in IONS in Q1 2014 and has held it in 11 quarters since. The position peaked at $458K in Q1 2015. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

CT Financial Advisors held 1,175 shares of Ionis Pharmaceuticals worth $47.2K as of Q1 2017.
CT Financial Advisors left its Ionis Pharmaceuticals share count unchanged in Q1 2017.
Ionis Pharmaceuticals made up 0.03% of CT Financial Advisors's portfolio in Q1 2017, its #279 holding.
CT Financial Advisors first reported a position in Ionis Pharmaceuticals in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's Ionis Pharmaceuticals position peaked at $458K in Q1 2015.
270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.